At a glance
ClinicalIndex Comparison RecordN/ACompleted· 30 enrolled
Drug / intervention
LiDCO rapid monitordevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Use of the LiDCORapid Monitor in Patients During Graded Phlebotomy and the Removal of Autologous Blood
In Brief
A clinical study evaluating LiDCO rapid monitor for Cardiac Surgery. Completed, enrolled 30 participants across 1 site.
Detailed Summary
This is a study to validate the utility and accuracy of the non-invasive device (LiDCOrapid monitor) during a period of phlebotomy and graded blood loss in patients who are having cardiac surgery.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiac Surgery
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
Enrollment StartMar 2012
First PostedMar 2012
Primary CompletionDec 2014
Study CompletionMar 2015
TodayJul 2026
First PostedMar 30, 2012
Enrollment StartMar 1, 2012
Primary CompletionDec 1, 2014
Study CompletionMar 1, 2015
TodayJul 2, 2026
Enrollment to primary: 2.8 yearsPosted 14.3 years ago
Interventions
LiDCO rapid monitordevice
Technology which provides a continuous means of monitoring various hemodynamic parameters including cardiac output and pulse pressure variability.